Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Jost

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cellsMehmet Kemal Tur, Inga Neef, Edgar Jost, et al.
International Journal of Molecular Sciences|February 22, 2018
Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid LiposarcomasMonica S Ventura Ferreira, Martina Crysandt, Till Braunschweig, et al.
Clinical Case Reports|March 14, 2022
Novel homozygous nonsense mutation in the P5'N-1 coding gene as an alternative cause for hereditary anemia with basophilic stipplingMartin Kirschner, Inga Rebecca Heinen, Steffen Koschmieder, et al.
Plos One|March 26, 2011
Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cellsThomas Walenda, Gudrun Bokermann, Edgar Jost, et al.
Plos One|May 30, 2015
MicroRNAs and Metabolites in Serum Change after Chemotherapy: Impact on Hematopoietic Stem and Progenitor CellsThomas Walenda, Yvonne Diener, Edgar Jost, et al.
Cancer Immunology, Immunotherapy : CII|October 17, 2015
Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivoChristian Cremer, Hanna Braun, Radoslav Mladenov, et al.
Leukemia|June 16, 2021
Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patternsTanja Božić, Chao-Chung Kuo, Jan Hapala, et al.
Blood Cells, Molecules & Diseases|August 17, 2014
DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML)Gemma E Logan, Nirit Mor-Vaknin, Till Braunschweig, et al.
European Journal of Haematology|June 28, 2020
Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosisSteffen Koschmieder, Edgar Jost, Christian Cornelissen, et al.
Epigenetics|September 22, 2011
Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myelomaStefan Wilop, Thomas B van Gemmeren, Marjolein H F M Lentjes, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cellsMehmet Kemal Tur, Inga Neef, Edgar Jost, et al.
International Journal of Molecular Sciences|February 22, 2018
Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid LiposarcomasMonica S Ventura Ferreira, Martina Crysandt, Till Braunschweig, et al.
Clinical Case Reports|March 14, 2022
Novel homozygous nonsense mutation in the P5'N-1 coding gene as an alternative cause for hereditary anemia with basophilic stipplingMartin Kirschner, Inga Rebecca Heinen, Steffen Koschmieder, et al.
Plos One|March 26, 2011
Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cellsThomas Walenda, Gudrun Bokermann, Edgar Jost, et al.
Plos One|May 30, 2015
MicroRNAs and Metabolites in Serum Change after Chemotherapy: Impact on Hematopoietic Stem and Progenitor CellsThomas Walenda, Yvonne Diener, Edgar Jost, et al.
Cancer Immunology, Immunotherapy : CII|October 17, 2015
Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivoChristian Cremer, Hanna Braun, Radoslav Mladenov, et al.
Leukemia|June 16, 2021
Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patternsTanja Božić, Chao-Chung Kuo, Jan Hapala, et al.
Blood Cells, Molecules & Diseases|August 17, 2014
DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML)Gemma E Logan, Nirit Mor-Vaknin, Till Braunschweig, et al.
European Journal of Haematology|June 28, 2020
Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosisSteffen Koschmieder, Edgar Jost, Christian Cornelissen, et al.
Epigenetics|September 22, 2011
Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myelomaStefan Wilop, Thomas B van Gemmeren, Marjolein H F M Lentjes, et al.
Pageof 11